Insider Transactions Reported by 23 Insiders of SOLENO THERAPEUTICS INC

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	8	-2,948,736	100%	$67.89	-$200,187,707
Net	-8	-2,948,736	-100%		-$200,187,707

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Abingworth LLP	10%+ Owner	$657,560,041			21 Dec 2018
Vivo Opportunity, LLC	10%+ Owner	$314,755,556	-$124,449,124	-28%	26 Mar 2025
PERCEPTIVE ADVISORS LLC	10%+ Owner	$112,175,587			26 Sep 2023
Carlyle Group Inc.	10%+ Owner	$55,874,902			28 Sep 2023
Anish Bhatnagar	CHIEF EXECUTIVE OFFICER, Director	$27,022,805	-$47,271,960	-64%	21 Jan 2026
James H. Mackaness	Chief Financial Officer	$6,100,521	-$6,293,177	-51%	21 Jan 2026
Meredith Manning	Chief Commercial Officer	$3,334,885	-$3,044,343	-48%	21 Jan 2026
Michael F. Huang	Sr. VP of Clinical Development	$2,148,514	-$1,013,627	-32%	21 Jan 2026
Kristen Yen	Officer title: SVP Global Clinical Operations and Patient Advocacy	$1,742,655	-$6,376,789	-79%	21 Jan 2026
Jennifer Fulk	Chief Financial Officer	$1,551,536			02 Mar 2026
William G. Harris	Director	$1,478,833			05 Jun 2025
Birgitte Volck	Director	$1,337,295			05 Jun 2025
SCHULER JACK W	10%+ Owner	$1,335,180			09 Dec 2022
Dawn Carter Bir	Director	$1,295,733			05 Jun 2025
Patricia C. Hirano	Officer title: Senior Vice President, Regulatory Affairs	$1,051,084	-$11,313,890	-91%	21 Jan 2026
ERNEST MARIO	Director	$966,848			06 Jun 2024
Manher Joshi	Chief Development Officer	$933,901			21 Jan 2026
Kevin Norrett	Chief Business Officer	$823,477			21 Jan 2026
Andrew Sinclair	Director	$800,043			05 Jun 2025
Matthew Pauls	Director	$800,043	-$424,797	-35%	05 Jun 2025
Mark W. Hahn	Director	$679,125			13 Oct 2025
Raymond W. Urbanski	Chief Development Officer				13 Aug 2024
Gwen A. Melincoff	Director				25 May 2023

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.